LeafNLP Demos
Back to explore

Report #2887657

Received Mar 4, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
ME
Recovered
Unknown
Vaccinated
Sep 9, 2025
Onset
Sep 9, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1——

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

Received RECOMBIVAX then Received HEPLISAV-B; Has Not Received Her Second Dose of HEPLISAV-B; Initial report received on 22-Jan-2026. A nurse reported that a 22-year-old female received RECOMBIVAX then HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 05-Aug-2025, the patient received dose 1 of a hepatitis B vaccine [RECOMBIVAX (lot number, route, and site not available)]. On 09-Sep-2025, the patient received dose 2 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. HEPLISAV-B was received at a different location. At the time of reporting, the patient had not received a second dose of HEPLISAV-B. No other side effects were reported. No other information was available. Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.

Other medications

Recombivax hb